ResQ Biotech
Greece - PatraBiotechnology
Focus: ResQ Biotech is a public biotechnology company founded in 2002 and headquartered in Patra, Greece, specializing in therapies for protein misfolding diseases. The company operates as a mid-cap biotech focused on an underserved therapeutic area with significant unmet medical need.
Profile data last refreshed 2h ago · AI intelligence enriched 1mo ago
Funding Stage
PUBLIC
Open Jobs
1+1 this month
Stable — net +1 jobs in 30d
3 added, 2 removed. Backfill posture.
Should You Work at ResQ Biotech?
AI assessmentResQ Biotech presents a specialized science opportunity but lacks visible hiring activity and transparency to confidently evaluate career trajectory or stability.
Why Work Here
- Focused therapeutic area (protein misfolding diseases) offers deep scientific specialization and potential to become a category leader
- Public company status provides liquidity, stability, and transparency compared to private peers
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Interview Prep Quick Facts
Help build intelligence for ResQ Biotech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.